A Phase 2b Dose Finding Study of RMC-035 in Participants Undergoing Open-chest Cardiac Surgery

Clinical trial NCT06475274 · COMPLETED

Trial details

NCT number: NCT06475274
Sponsor: Guard Therapeutics AB
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Kidney Injury Following Open-Chest Cardiac Surgery

Start date: 2024-08-26
Primary completion: 2025-09-11
Enrollment: 170

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.